BNP Paribas Financial Markets
OLMA icon

BNP Paribas Financial Markets’s Olema Pharmaceuticals OLMA Stock Holding History

BNP Paribas Financial Markets’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$323K Buy
21,670
+11,308
+109% +$252K ﹤0.01% 3824
2025
Q4 		$259K Sell
10,362
-289,257
-97% -$5.15M ﹤0.01% 3936
2025
Q3 		$2.93M Buy
299,619
+293,034
+4,450% +$1.76M ﹤0.01% 2337
2025
Q2 		$28.1K Sell
6,585
-361,519
-98% -$1.61M ﹤0.01% 4468
2025
Q1 		$1.38M Buy
368,104
+174,356
+90% +$877K ﹤0.01% 2564
2024
Q4 		$1.13M Buy
+193,748
New +$1.94M ﹤0.01% 2735

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

BNP Paribas Financial Markets's OLMA Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Olema Pharmaceuticals (OLMA) stake by 109% in Q1 2026, buying an estimated $252K and bringing the position to 21,670 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #3824.

BNP Paribas Financial Markets first reported a position in OLMA in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.93M in Q3 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • BNP Paribas Financial Markets held 21,670 shares of Olema Pharmaceuticals worth $323K as of Q1 2026.
  • BNP Paribas Financial Markets bought 11,308 Olema Pharmaceuticals shares in Q1 2026, an estimated $252K.
  • Olema Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #3824 holding.
  • BNP Paribas Financial Markets first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Olema Pharmaceuticals position peaked at $2.93M in Q3 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.